Logo

Ares Genetics: Arne Materna, Andreas Posch, Achim Plum

Dec 09, 2020

OpGen subsidiary Ares Genetics has announced founding CEO and Managing Director Andreas Posch and Managing Director Achim Plum will step down from their positions, effective Dec. 31. They will both stay on as special advisors throughout 2021 to ensure a smooth transition.

Arne Materna has been appointed managing director and CEO, effective Jan. 1. Materna previously served as vice president, products at CosmosID and has held leadership roles at Qiagen, CLCbio, and Pacific Biosciences. He has particular expertise in microbiology and next-generation sequencing and has experience developing bioinformatics platforms and products.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.